Bibliografía

PATOLOGIA VENOSA:

  1. Orbach E.J. Contributions to the therapy of the varicose complex. J Int Coll Surg 1950; 29: 765-71.
  2. Monfreux A. Traitement  sclerosant  des troncs saphéniens et leurs collaterales de gros calibre par la methode MUS. Phlébologie 2000; 129-33.
  3. Tessari L. Nouvelle technique d´obtention de la scléromousse. Phlébologie 2000; 53: 129-33.
  4. Hamel-Desnos C, Allaert FA, Benigni J, Boilette G, Chleir F, Ouvry P et al.  Polodocanol foam 3% versus 1% in the great saphenous vein: Early results. Phlebology 2005; 58: 175-82.
  5. Breu F.X., Guggenbichleir S. European Consensus meeting on foam Sclerotherapy, April 4-6, 2003, Tegermsee, Germany. Dermatol Surg 2004, 30: 709-17.
  6. Tessari L. 8º International Phlébologie Symposium, Bologna, Italy, 2006.
  7. Guex J. J. , Allaert F.A., Gillet J, Chleir F., Inmediate and midterm complications of sclerotherapy: Report of a prospective multicenter registry of 12173 sclerotherapy sessions. Dermat Surg 2005; 31: 123-8.
  8. Tessari L., Cavezzi A., Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58-60.
  9. Gobin J., French experience with sclerotherapy. Angiologia E Cirigia Vascular, Ubelandia, Brazil, 2008.
  10. Jia X., Mowatt g., Burr J.M., Cassar K., Cook J., Fraser C., Sistematic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94: 925-36.
  11. Samama BM. Prévention  de la thrombose veineuse des members inférieurs. In: Priollet P., Samama M.M., Thrombose veineuse, Paris, Doin Editeurs, 1994.
  12. Laroche J.P., Righini M. Thrombose veineuse, mode d´emploi. Ed. Sauramps Medical, 2004, Montpellier.
  13. Sala Planell E, Gesto R, Jimenez Cosio JA. Epidemiologia y repercusiones sociosanitarias de la patología venosa. Estudio DETECT-IVC. An Cirug Card Vasc 2001; 7(1): 14-17.
  14. Geerts WH., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., et al. Prevention of venous thromboembolism : the seventh ACCP conference of antithrombotic and thrombolytic therapy. Chets 2004; 1(26) (sup 3): 338S-400S.

PATOLOGIA DE LA MICROCIRCULACION:

  1. Priollet P. Acrosyndromes vasculaires. Encycl Med Chir (Elservier Paris), Dermatologie, 98-550-A-10, 1999, 10p.
  2. Roman Ivorra J A., Gonzálvez Perales JL., Fernandez Carballido C., Graña J., Torres MJ. Prevalence of Raynaud´s phenomen in general practice in the east of Spain. Clin Reumatol. 2001; 20: 88-90.
  3. Carpentier P., Satger B., Poensin D., Maricq H. Incidence andnatural history of Raynaud phenomenom:  along-term follow up (14 years) of a random sample from the general population. J Vasc Surg 2006; 44: 1032-8.
  4. Carpentier P.New techniques for clinical assessment of the peripheral microcirculation. Drugs, 1999. 58: 17-22.

PATOLOGIA ARTERIAL:

  1. Mc Gill HC., Mcmahan CA., Herderich EE et AL.Effects of coronary heart disease risk factors on atherosclerosis of  selected regions of the aorta and right coronary artery: PDAY research group, Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Tromb Vasc Biol 2000; 20: 836-45.
  2. Virmani R, Burke AP., Farb A., Kolodgie F D. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13-8.
  3. Greenland P, Abrams J, Aurigemma GP et AL. Prevention conference V: beyong secondary prevention , identifying the high – risk patient for primary prevention , non invasive tests of athero-sclerotic burden. Circulation 2000; 101: E16-22.

PATOLOGIA LINFATICA

  1. Brunner U et Coll. Epidemiology and clinic of primary lymphoedema exemplified by 5oo cases. The Initial Lymphatics, Ed a. Bolinger, H Partsch., j.H.N Wolfe Gerog Thiele Verlag 1985: 7-14.
  2. Coupé M et Coll.. Vivre mieux le lymphoèdeme . Livre 7 Cd- Forums, 6º Journées Nationales de l´AFFCA , Montpellier  1999, 261-305.
  3. Janbon Ch., Soulier Sotto V. Lymphoedeme primaire . Encycl Med Chir (Elservier, Paris), Angéiologie, 19-3010, 1997, 7p.
  4. Janbon Ch.,Lymphologie. Collecttion de Médecine Vasculaire, Nº3, 1994, 200p, 83 figures, Editions Lasson.

 

volver atrás

Enlaces:

  Consulta médica autorizada por la Generalitat de Catalunya   Web Médica Acreditada. Ver más
información VER CERTIFICADO WMA               Doctoralia es la plataforma líder mundial que conecta profesionales de la salud con pacientes, transformando y mejorando la relación entre ellos           

Aviso Legal / Protección de datos
Última actualización, 11/2019